BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
14493 results:

  • 1. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values.
    Rogic I; Golubic AT; Zuvic M; Smitran T; Jukic N; Gamulin M; Kastelan Z; Huic D
    Nucl Med Rev Cent East Eur; 2024; 27(0):6-12. PubMed ID: 38680016
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
    Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
    World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
    Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
    Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. treatment of Osteoporosis in Men on Androgen Deprivation Therapy in Japan.
    Nishimoto H; Inui A; Mifune Y; Yamaura K; Bando Y; Okamura Y; Hara T; Terakawa T; Kuroda R
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674197
    [No Abstract]    [Full Text] [Related]  

  • 5. Regulation of Molecular Biomarkers Associated with the Progression of prostate cancer.
    Martin-Caraballo M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673756
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer.
    Yang L; Tang Y; Zhang Y; Wang Y; Jiang P; Liu F; Feng N
    Sci Rep; 2024 Apr; 14(1):9570. PubMed ID: 38671021
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Breakthrough electroneutron multi-response miniature dosimetry/spectrometry in medical accelerator.
    Sohrabi M; Malekitakbolagh M; Nedaei HA
    Sci Rep; 2024 Apr; 14(1):9557. PubMed ID: 38664481
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study.
    Jahnen M; Amiel T; Kirchoff F; Büchler JW; Herkommer K; Rothe K; Meissner VH; Gschwend JE; Lunger L
    World J Urol; 2024 Apr; 42(1):260. PubMed ID: 38664275
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using
    Muralidhar A; Hernandez R; Morris ZS; Comas Rojas H; Bio Idrissou M; Weichert JP; McNeel DG
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38663936
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
    Lee LJ; Han CJ; Saligan L; Wallen GR
    Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
    Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
    Elife; 2024 Apr; 13():. PubMed ID: 38656229
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [
    Arbuznikova D; Klotsotyra A; Uhlmann L; Domogalla LC; Steinacker N; Mix M; Niedermann G; Spohn SKB; Freitag MT; Grosu AL; Meyer PT; Gratzke C; Eder M; Zamboglou C; Eder AC
    Theranostics; 2024; 14(6):2560-2572. PubMed ID: 38646643
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
    Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
    [No Abstract]    [Full Text] [Related]  

  • 14. Surgical management of rectal cancer with synchronous treatment of prostate cancer.
    Brière R; Martin AG; Letarte F; Fournier FR; Bouchard P; Drolet S
    Langenbecks Arch Surg; 2024 Apr; 409(1):133. PubMed ID: 38642125
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Patterns of Care for Medicare Beneficiaries With Metastatic prostate cancer.
    Filson CP; Richards TB; Ekwueme DU; Howard DH
    Urol Pract; 2024 May; 11(3):489-497. PubMed ID: 38640419
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Influence factors of erectile dysfunction in patients with localized prostate cancer after radical surgery].
    Wang SH; Shi XQ; Ma MF; Jin XX; Zhao XD; Zhou YL; Gu YF; Hu J; Dong N; Dong J; Xu S
    Zhonghua Nan Ke Xue; 2023 Dec; 29(12):992-999. PubMed ID: 38639951
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [LncRNA RPL22P1-201 affects prostate cancer cell proliferation, cell cycle, and sensitivity to docetaxel by regulating miR-216b-5p expression].
    Yang C; Xue JG
    Zhonghua Nan Ke Xue; 2023 Oct; 29(10):881-887. PubMed ID: 38639656
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
    Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
    Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy.
    Rodler S; Danninger D; Eismann L; Kazmierczak PM; Jokisch F; Li M; Becker A; Kretschmer A; Stief C; Westhofen T
    World J Urol; 2024 Apr; 42(1):242. PubMed ID: 38635030
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway.
    You X; Qiu J; Li Q; Zhang Q; Sheng W; Cao Y; Fu W
    BMC Cancer; 2024 Apr; 24(1):472. PubMed ID: 38622523
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 725.